Advertisement

Tumor Biology

, Volume 36, Issue 3, pp 1781–1789 | Cite as

Up-regulation of 14-3-3ζ expression in intrahepatic cholangiocarcinoma and its clinical implications

  • Chi Zhang
  • Li-Xin Liu
  • Zhao-Ru Dong
  • Guo-Ming Shi
  • Jia-Bin Cai
  • Peng-Fei Zhang
  • Ai-Wu Ke
  • Jing-Xian Yu
  • Jian Zhou
  • Jia Fan
Research Article

Abstract

The 14-3-3 proteins are highly conserved molecules that are involved in many vital biologic processes and are associated with the progression of cancer. The role of 14-3-3ζ, a dimeric isoform of 14-3-3, in intrahepatic cholangiocarcinoma (ICC) was investigated in this study. The expression of 14-3-3ζ in tumour samples from patients with ICC was examined by Western blot and immunohistochemistry, and the correlation between its expression and various clinicopathological features was determined. Then, the capacity for invasion, migration and proliferation as well as the expression of epithelial–mesenchymal transition (EMT)-related markers in ICC cells were assessed after 14-3-3ζ depletion. Finally, the prognostic significance of 14-3-3ζ in patients with ICC was further evaluated by Kaplan–Meier and Cox regression analyses. The expression of 14-3-3ζ was significantly higher in ICC tissues compared to peritumoural tissues. High expression of 14-3-3ζ positively correlated with lymphatic metastasis and tumour–node–metastasis (TNM) stage. The inhibition of 14-3-3ζ expression was able to impair the invasion, migration and proliferation of ICC cells in vitro. The expression of 14-3-3ζ was significantly correlated with the expression of the EMT-related markers snail and E-cadherin in ICC samples. Moreover, the down-regulation of 14-3-3ζ also decreased the phosphorylation of extracellular signal-regulated kinase (ERK) in ICC cells. Clinically, patients with ICC with high 14-3-3ζ expression demonstrated a poor prognosis in terms of a short overall survival and a high recurrence rate of the disease. A multivariate analysis revealed that 14-3-3ζ overexpression was an independent prognostic indicator for patients with ICC. 14-3-3ζ may enhance the invasive and proliferative capacity of tumour cells and thus prompt the progression of ICC via the activation of ERK signalling and the induction of EMT. The overexpression of 14-3-3ζ may be used as a prognostic biomarker and therapeutic target in patients with ICC.

Keywords

14-3-3ζ Intrahepatic cholangiocarcinoma Epithelial-mesenchymal transition Metastasisᅟ 

Notes

Acknowledgments

This study was supported by the National Key Sci-Tech Project (2012ZX10002011-002) the National Natural Science Foundation of China (81172023, 81071741 and 81030038), Shanghai Municipal Natural Science Foundation (14ZR1405800) and the Ph.D. Programs Foundation of the Ministry of Education of China (20110072120050).

Conflicts of interest

None

Supplementary material

13277_2014_2780_MOESM1_ESM.docx (14 kb)
ESM 1 (DOCX 14 kb)
13277_2014_2780_MOESM2_ESM.docx (14 kb)
ESM 2 (DOCX 13 kb)
13277_2014_2780_MOESM3_ESM.docx (16 kb)
ESM 3 (DOCX 16 kb)

References

  1. 1.
    Razumilava N, Gores GJ. Cholangiocarcinoma. Lancet 2014Google Scholar
  2. 2.
    Jemal A, Bray F, Center MM, et al. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMedGoogle Scholar
  3. 3.
    Khan SA, Emadossadaty S, Ladep NG, et al. Rising trends in cholangiocarcinoma: is the ICD classification system misleading us? J Hepatol. 2012;56:848–54.CrossRefPubMedGoogle Scholar
  4. 4.
    Everhart JE, Ruhl CE. Burden of digestive diseases in the United States. Part III: Liver, biliary tract, and pancreas. Gastroenterology. 2009;136:1134–44.CrossRefPubMedGoogle Scholar
  5. 5.
    Aitken A. 14-3-3 proteins: a historic overview. Semin Cancer Biol. 2006;16:162–72.CrossRefPubMedGoogle Scholar
  6. 6.
    Morrison DK. The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol. 2009;19:16–23.CrossRefPubMedGoogle Scholar
  7. 7.
    Freeman AK, Morrison DK. 14-3-3 proteins: diverse functions in cell proliferation and cancer progression. Semin Cell Dev Biol. 2011;22:681–7.CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Frasor J, Chang EC, Komm B, et al. Gene expression preferentially regulated by tamoxifen in breast cancer cells and correlations with clinical outcome. Cancer Res. 2006;66:7334–40.CrossRefPubMedGoogle Scholar
  9. 9.
    Neal CL, Yu D. 14-3-3ζ as a prognostic marker and therapeutic target for cancer. Expert Opin Ther Targets. 2010;14:1343–54.CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Niemantsverdriet M, Wagner K, Visser M, et al. Cellular functions of 14-3-3 zeta in apoptosis and cell adhesion emphasize its oncogenic character. Oncogene. 2008;27:1315–9.CrossRefPubMedGoogle Scholar
  11. 11.
    Fan T, Li R, Todd NW, et al. Up-regulation of 14-3-3zeta in lung cancer and its implication as prognostic and therapeutic target. Cancer Res. 2007;67:7901–6.CrossRefPubMedGoogle Scholar
  12. 12.
    Maxwell SA, Li Z, Jaye D, et al. 14-3-3zeta mediates resistance of diffuse large B cell lymphoma to an anthracycline-based chemotherapeutic regimen. J Biol Chem. 2009;284:22379–89.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Lu J, Guo H, Treekitkarnmongkol W, et al. 14-3-3zeta cooperates with ErbB2 to promote ductal carcinoma in situ progression to invasive breast cancer by inducing epithelial-mesenchymal transition. Cancer Cell. 2009;16:195–207.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Huang XY, Ke AW, Shi GM, et al. AlphaB-crystallin complexes with 14-3-3zeta to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma. Hepatology. 2013;57:2235–47.CrossRefPubMedGoogle Scholar
  15. 15.
    Wittekind C. Pitfalls in the classification of liver tumors. Pathologe. 2006;27:289–93.CrossRefPubMedGoogle Scholar
  16. 16.
    Edge SB, Compton CC. The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM. Ann Surg Oncol. 2010;17:1471–4.CrossRefPubMedGoogle Scholar
  17. 17.
    Ke AW, Shi GM, Zhou J, et al. Role of overexpression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology. 2009;49:491–503.CrossRefPubMedGoogle Scholar
  18. 18.
    Zhang C, Bai DS, Huang XY, et al. Prognostic significance of Capn4 overexpression in intrahepatic cholangiocarcinoma. PLoS One. 2013;8:e54619.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Ke AW, Shi GM, Zhou J, et al. CD151 amplifies signaling by integrin alpha6beta1 to PI3K and induces the epithelial-mesenchymal transition in HCC cells. Gastroenterology. 2011;140:1629–41. e15.CrossRefPubMedGoogle Scholar
  20. 20.
    Bai DS, Dai Z, Zhou J, et al. Capn4 overexpression underlies tumor invasion and metastasis after liver transplantation for hepatocellular carcinoma. Hepatology. 2009;49:460–70.CrossRefPubMedGoogle Scholar
  21. 21.
    Neal CL, Yao J, Yang W, et al. 14-3-3zeta overexpression defines high risk for breast cancer recurrence and promotes cancer cell survival. Cancer Res. 2009;69:3425–32.CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Zhao GY, Ding JY, Lu CL, et al. The overexpression of 14-3-3zeta and Hsp27 promotes non-small cell lung cancer progression. Cancer. 2014;120:652–63.CrossRefPubMedGoogle Scholar
  23. 23.
    Wu Q, Liu CZ, Tao LY, et al. The clinicopathological and prognostic impact of 14-3-3 protein isoforms expression in human cholangiocarcinoma by immunohistochemistry. Asian Pac J Cancer Prev. 2012;13:1253–9.CrossRefPubMedGoogle Scholar
  24. 24.
    Zhao J, Meyerkord CL, Du Y, et al. 14-3-3 proteins as potential therapeutic targets. Semin Cell Dev Biol. 2011;22:705–12.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Lin M, Morrison CD, Jones S, et al. Copy number gain and oncogenic activity of YWHAZ/14-3-3zeta in head and neck squamous cell carcinoma. Int J Cancer. 2009;125:603–11.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Barrallo-Gimeno A, Nieto MA. The Snail genes as inducers of cell movement and survival: implications in development and cancer. Development. 2005;132:3151–61.CrossRefPubMedGoogle Scholar
  27. 27.
    Hou Z, Peng H, White DE, et al. 14-3-3 binding sites in the snail protein are essential for snail-mediated transcriptional repression and epithelial-mesenchymal differentiation. Cancer Res. 2010;70:4385–93.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Bartkova J, Horejsi Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature. 2005;434:864–70.CrossRefPubMedGoogle Scholar
  29. 29.
    Gardino AK, Yaffe MB. 14-3-3 proteins as signaling integration points for cell cycle control and apoptosis. Semin Cell Dev Biol. 2011;22:688–95.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Fischer A, Baljuls A, Reinders J, et al. Regulation of RAF activity by 14-3-3 proteins: RAF kinases associate functionally with both homo- and heterodimeric forms of 14-3-3 proteins. J Biol Chem. 2009;284:3183–94.CrossRefPubMedGoogle Scholar

Copyright information

© International Society of Oncology and BioMarkers (ISOBM) 2014

Authors and Affiliations

  • Chi Zhang
    • 1
    • 2
  • Li-Xin Liu
    • 3
  • Zhao-Ru Dong
    • 1
    • 2
  • Guo-Ming Shi
    • 1
    • 2
  • Jia-Bin Cai
    • 1
    • 2
  • Peng-Fei Zhang
    • 1
    • 2
  • Ai-Wu Ke
    • 1
    • 2
  • Jing-Xian Yu
    • 1
    • 2
  • Jian Zhou
    • 1
    • 2
  • Jia Fan
    • 1
    • 2
    • 4
  1. 1.Liver Cancer Institute, Zhongshan HospitalFudan UniversityShanghaiPeople’s Republic of China
  2. 2.Key Laboratory of Carcinogenesis and Cancer Invasion (Fudan University)Ministry of EducationShanghaiPeople’s Republic of China
  3. 3.Department of Hepatobiliary SurgeryThe Second Affiliated Hospital of Kunming Medical CollegeKunmingPeople’s Republic of China
  4. 4.Cancer Center, Institutes of Biomedical SciencesFudan UniversityShanghaiPeople’s Republic of China

Personalised recommendations